Navigation Links
PAREXEL Announces Date of Third Quarter Fiscal Year 2009 Earnings Release and Conference Call

BOSTON, March 26 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) will release Third Quarter Fiscal Year 2009 financial results on Monday, April 27, 2009 after the close of the stock market. The announcement will be available on PAREXEL's website at and on the PR Newswire website at

PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Tuesday, April 28, 2009 to discuss the results. To access the webcast, visit PAREXEL's website at and click on the Investors menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial (706) 679-6476 and ask to join PAREXEL's Third Quarter Fiscal Year 2009 Earnings Conference Call.

About the Company

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 51 countries around the world, and has over 9,250 employees. For more information about PAREXEL International visit

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

    CONTACT:     Jill Baker, Vice President of Investor Relations

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PAREXEL International to Present at Raymond James 30th Annual Institutional Investors and the Barclays Capital Global Healthcare Conferences
2. PAREXEL Consulting Enhances European Regulatory Affairs Capabilities With Appointment of Medical Products Agency Expert Dr. Anders Neil
3. PAREXEL Reports Second Quarter Fiscal Year 2009 Financial Results
4. PAREXEL Announces Date of Second Quarter Fiscal Year 2009 Earnings Release and Conference Call
5. PAREXEL Reports Preliminary Second Quarter Results
6. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
7. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
8. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
9. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
10. Women's Health Services Announces New Associate
11. Surgical Care Affiliates Announces Investor Conference Call to Discuss 2008 Fourth Quarter and Year-End Results
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again with ... the possibilities are endless. Users have full control over angle of view, speed method, ... users are sure to get heads to turn. , ProPanel: Pulse offers fully customizable ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... out by the University of Toronto and the University of British Columbia suggested that ... for head injuries. The article explains that part of the reason for the controversial ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... ... 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that will ... their purchase of lice treatment product. In addition, customers will receive a complimentary head ... “Finding lice is a sure way to ruin the holidays, so we encourage all ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Linden Care, ... and optimizing treatment outcomes for patients suffering from chronic ... request for a Temporary Restraining Order (TRO) enjoining Express ... the two companies. --> ... pursuing all of its legal options. ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology: